tiprankstipranks
Dianthus Therapeutics (DNTH)
NASDAQ:DNTH
US Market
DNTH
Dianthus Therapeutics
RESEARCH TOOLSreports
Want to see DNTH full AI Analyst Report?

Dianthus Therapeutics (DNTH) Stock News & Sentiment

432 Followers
Dianthus Therapeutics Stockholders Reaffirm Board and Governance Structure
Premium
Company Announcements
Dianthus Therapeutics Stockholders Reaffirm Board and Governance Structure
18d ago
8K
DNTH
Dianthus Therapeutics: Best-in-Class C1s Antibody Claseprubart and Strong Execution Support Outperform Rating
Premium
Ratings
Dianthus Therapeutics: Best-in-Class C1s Antibody Claseprubart and Strong Execution Support Outperform Rating
2M ago
DNTH
Bullish View on Dianthus: Claseprubart’s Differentiated Complement Inhibition and Underappreciated Bifunctional Pipeline Drive Buy Rating
Premium
Ratings
Bullish View on Dianthus: Claseprubart’s Differentiated Complement Inhibition and Underappreciated Bifunctional Pipeline Drive Buy Rating
2M ago
DNTH
Dianthus Highlights Strong Cash Runway and Streamlined Trials
Premium
Company Announcements
Dianthus Highlights Strong Cash Runway and Streamlined Trials
3M ago
8K
DNTH
Dianthus Therapeutics Announces Major Public Equity Offering
Premium
Company Announcements
Dianthus Therapeutics Announces Major Public Equity Offering
3M ago
8K
DNTH
AI Integration Exposes Dianthus Therapeutics to Heightened Cyber, Privacy, and Reputational Risks
Premium
Company Announcements
AI Integration Exposes Dianthus Therapeutics to Heightened Cyber, Privacy, and Reputational Risks
3M ago
DNTH
Dianthus Advances Claseprubart With Positive Phase 3 Update
Premium
Company Announcements
Dianthus Advances Claseprubart With Positive Phase 3 Update
3M ago
8K
DNTH
More DNTH News >

DNTH News on the Web

Why Dianthus Therapeutics Shares Are Sinking Today
TipRanks News
Bearish
Dianthus Therapeutics Stockholders Reaffirm Board and Governance Structure
TipRanks News
Neutral
Dianthus Therapeutics Stock Surges On Trial Breakthrough
TipRanks News
Bullish
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally | The Motley Fool
Motley Fool
Bullish
Dianthus price target lowered to $120 from $122 at Evercore ISI
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Tenax Therapeutics (TENX) and Compass Therapeutics (CMPX)
TipRanks News
Neutral
Truist Financial Sticks to Its Buy Rating for Dianthus Therapeutics (DNTH)
TipRanks News
Bullish
Dianthus price target raised to $125 from $123 at Raymond James
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average3.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DNTH’s Media Buzz Sentiment?
Currently, no data Available
What is DNTH’s weekly average amount of articles?
In an average week, 3.25 articles about DNTH are published.
    What is DNTH’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    VEEVVeeva Systems
    NRIXNurix Therapeutics
    MDTMedtronic
    GMRSGMR Solutions, Inc. Class A
    RHCGFRyman Healthcare
    Showing the stocks with the most bullish news sentiment over the past week